North America Clinical Trial Imaging Market

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2028

Analysis - by Modality [Tomography, Magnetic Resonance Imaging (MRI), Ultrasound, Positron Emission Tomography (PET), X-Ray, Echocardiography, and Others], Offering (Operational Imaging Services, Imaging Software, Read Analysis Services, Trial Design and Consulting Services, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Others]

No. of Pages: 124
Report Code: BMIRE00028633
Category: Life Sciences
North America Clinical Trial Imaging Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. North America Clinical Trial Imaging Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. North America Clinical Trial Imaging Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. North America Clinical Trial Imaging Market Regional Analysis

6.2 North America Clinical Trial Imaging Market Revenue 2021-2028 (US$ Million)
6.3 North America Clinical Trial Imaging Market Forecast Analysis

7. North America Clinical Trial Imaging Market Analysis – by Modality

7.1 Tomography
  • 7.1.1 Overview
  • 7.1.2 Tomography: North America Clinical Trial Imaging Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.2 Magnetic Resonance Imaging
  • 7.2.1 Overview
  • 7.2.2 Magnetic Resonance Imaging: North America Clinical Trial Imaging Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.3 Ultrasound
  • 7.3.1 Overview
  • 7.3.2 Ultrasound: North America Clinical Trial Imaging Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.4 Positron Emission Tomography
  • 7.4.1 Overview
  • 7.4.2 Positron Emission Tomography: North America Clinical Trial Imaging Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.5 X-Ray
  • 7.5.1 Overview
  • 7.5.2 X-Ray: North America Clinical Trial Imaging Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.6 Echocardiography
  • 7.6.1 Overview
  • 7.6.2 Echocardiography: North America Clinical Trial Imaging Market – Revenue and Forecast, 2021-2028 (US$ Million)

8. North America Clinical Trial Imaging Market Analysis – by Offering

8.1 Operational Imaging Services
  • 8.1.1 Overview
  • 8.1.2 Operational Imaging Services: North America Clinical Trial Imaging Market – Revenue and Forecast, 2021-2028 (US$ Million)
8.2 Imaging Software
  • 8.2.1 Overview
  • 8.2.2 Imaging Software: North America Clinical Trial Imaging Market – Revenue and Forecast, 2021-2028 (US$ Million)
8.3 Read Analysis Services
  • 8.3.1 Overview
  • 8.3.2 Read Analysis Services: North America Clinical Trial Imaging Market – Revenue and Forecast, 2021-2028 (US$ Million)
8.4 Trial Design and Consulting Services
  • 8.4.1 Overview
  • 8.4.2 Trial Design and Consulting Services: North America Clinical Trial Imaging Market – Revenue and Forecast, 2021-2028 (US$ Million)

9. North America Clinical Trial Imaging Market Analysis – by End User

9.1 Contract Research Organizations
  • 9.1.1 Overview
  • 9.1.2 Contract Research Organizations: North America Clinical Trial Imaging Market – Revenue and Forecast, 2021-2028 (US$ Million)
9.2 Pharmaceutical and Biotechnology Companies
  • 9.2.1 Overview
  • 9.2.2 Pharmaceutical and Biotechnology Companies: North America Clinical Trial Imaging Market – Revenue and Forecast, 2021-2028 (US$ Million)
9.3 Academic and Research Institutes
  • 9.3.1 Overview
  • 9.3.2 Academic and Research Institutes: North America Clinical Trial Imaging Market – Revenue and Forecast, 2021-2028 (US$ Million)
9.4 Others
  • 9.4.1 Overview
  • 9.4.2 Others: North America Clinical Trial Imaging Market – Revenue and Forecast, 2021-2028 (US$ Million)

10. North America Clinical Trial Imaging Market – North America Analysis

10.1 Overview

10.2 North America
  • 10.2.1 North America Clinical Trial Imaging Market Breakdown, by Key Country, 2024 and 2028 (%)
  • 10.2.1.1 North America Clinical Trial Imaging Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 US: North America Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.1.1 US: North America Clinical Trial Imaging Market Breakdown, by Modality
    • 10.2.1.1.2 US: North America Clinical Trial Imaging Market Breakdown, by Offering
    • 10.2.1.1.3 US: North America Clinical Trial Imaging Market Breakdown, by End User
  • 10.2.1.2 Canada: North America Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.2.1 Canada: North America Clinical Trial Imaging Market Breakdown, by Modality
    • 10.2.1.2.2 Canada: North America Clinical Trial Imaging Market Breakdown, by Offering
    • 10.2.1.2.3 Canada: North America Clinical Trial Imaging Market Breakdown, by End User
  • 10.2.1.3 Mexico : North America Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.3.1 Mexico : North America Clinical Trial Imaging Market Breakdown, by Modality
    • 10.2.1.3.2 Mexico : North America Clinical Trial Imaging Market Breakdown, by Offering
    • 10.2.1.3.3 Mexico : North America Clinical Trial Imaging Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 BioTelemetry Inc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Calyx Inc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 eResearch Technology Inc
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 ICON PLC
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 IXICO plc
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Medical Metrics Inc
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Medpace Holdings Inc
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 VIDA Diagnostics Inc
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 WCG Clinical Inc
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - North America Clinical Trial Imaging Market

  • BioTelemetry Inc
  • Calyx Inc
  • eResearch Technology Inc
  • ICON PLC
  • IXICO plc
  • Medical Metrics Inc
  • Medpace Holdings Inc
  • VIDA Diagnostics Inc
  • WCG Clinical Inc
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)